The decision to buy Teva Pharmaceutical Industries (TEVA) depends on your investment horizon, as the company is currently in a "transition year". Analysts generally maintain a bullish long-term outlook, but near-term results are expected to be mixed. Current Price : ~31.26 USD (NYSE) or 9,408 ILA (TLV). 52-Week Range : $14.81 – $37.35.
: Consensus "Strong Buy" with an average price target around $38.78. Teva Pharmaceutical Industries Ltd (TEVA) ILA 8,025.00 17.23% since Jan 2, 2025 As of Apr 28, 17:00 GMT+3 • Disclaimer Apr 28, 2026 Open9,330.00 Mkt cap$37.02B USD 52-wk high11,350.00 High9,425.00 P/E ratio25.96 52-wk low5,305.00 Low9,253.00 Div yield- Investment Considerations